| 0093-0221 | These highlights do not include all the information needed to use risperidone tablets USP safely and effectively. See full prescribing information for risperidone tablets USP. RISPERIDONE tablets USP for oral use Initial U.S. Approval: 1993 | Contract Pharmacy Services-PA |
| 0093-0225 | These highlights do not include all the information needed to use risperidone tablets USP safely and effectively. See full prescribing information for risperidone tablets USP. RISPERIDONE tablets USP for oral use Initial U.S. Approval: 1993 | Contract Pharmacy Services-PA |
| 0093-7240 | These highlights do not include all the information needed to use risperidone tablets USP safely and effectively. See full prescribing information for risperidone tablets USP. RISPERIDONE tablets USP for oral use Initial U.S. Approval: 1993 | Contract Pharmacy Services-PA |
| 0093-7241 | These highlights do not include all the information needed to use risperidone tablets USP safely and effectively. See full prescribing information for risperidone tablets USP. RISPERIDONE tablets USP for oral use Initial U.S. Approval: 1993 | Contract Pharmacy Services-PA |
| 0093-7241 | These highlights do not include all the information needed to use risperidone tablets USP safely and effectively. See full prescribing information for risperidone tablets USP. Risperidone tablets USP for oral use Initial U.S. Approval: 1993 | State of Florida DOH Central Pharmacy |
| 0093-7242 | These highlights do not include all the information needed to use risperidone tablets USP safely and effectively. See full prescribing information for risperidone tablets USP. RISPERIDONE tablets USP for oral use Initial U.S. Approval: 1993 | Contract Pharmacy Services-PA |
| 0093-7243 | These highlights do not include all the information needed to use risperidone tablets USP safely and effectively. See full prescribing information for risperidone tablets USP. RISPERIDONE tablets USP for oral use Initial U.S. Approval: 1993 | Contract Pharmacy Services-PA |
| 0378-3505 | These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993 | State of Florida DOH Central Pharmacy |
| 0378-3511 | These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993 | Aphena Pharma Solutions - Tennessee, LLC |
| 0378-3512 | These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993 | State of Florida DOH Central Pharmacy |
| 0378-3512 | These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993 | Aphena Pharma Solutions - Tennessee, LLC |
| 0378-3513 | These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993 | Aphena Pharma Solutions - Tennessee, LLC |
| 0378-3514 | These highlights do not include all the information needed to use risperidone tablets safely and effectively. See full prescribing information for risperidone tablets. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993 | Aphena Pharma Solutions - Tennessee, LLC |
| 0480-1200 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-1200-21 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-1232 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-1232-08 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-1342 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-1342-08 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-1453 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-1453-08 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-1554 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-1554-08 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-9732 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-9732-01 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-9733 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-9733-01 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-9734 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-9734-01 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-9735 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0480-9735-01 | These highlights do not include all the information needed to use RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for RISPERIDONE FOR EXTENDED-RELEASE INJECTABLE SUSPENSION . RISPERIDONE for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2003 | Teva Pharmaceuticals, Inc. |
| 0555-1771 | These highlights do not include all the information needed to use Risperidone Tablets . See full prescribing information for Risperidone Tablets. Initial U.S. Approval 1993 | DOH CENTRAL PHARMACY |
| 0603-5686 | These highlights do not include all the information needed to use Risperidone tablets USP safely and effectively. See full prescribing information for Risperidone tablets USP. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993 | State of Florida DOH Central Pharmacy |
| 0603-5689 | These highlights do not include all the information needed to use Risperidone tablets USP safely and effectively. See full prescribing information for Risperidone tablets USP. Risperidone Tablets USP, for oral use Initial U.S. Approval: 1993 | State of Florida DOH Central Pharmacy |
| 0615-8196 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8196-05 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8196-30 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8196-39 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8197 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8197-05 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8197-30 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8197-39 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8198 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8198-05 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8198-39 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8265 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8265-39 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8288 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0615-8288-39 | These highlights do not include all the information needed to use Risperidone safely and effectively. See full prescribing information for Risperidone Tablets. Risperidone Tablets, USP, for oral use Initial U.S. Approval: 1993 | NCS HealthCare of KY, LLC dba Vangard Labs |
| 0904-7360 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7360-61 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7361 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7361 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Cardinal Health 107, LLC |
| 0904-7361-61 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7362 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7362 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Cardinal Health 107, LLC |
| 0904-7362-61 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7363 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7363-61 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7364 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7364-61 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7365 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 0904-7365-61 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Major Pharmaceuticals |
| 12496-0090 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0090-1 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0090-2 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0090-5 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0090-9 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0120 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0120-1 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0120-2 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0120-5 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0120-9 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0589 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0589-2 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0589-5 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0776 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0776-2 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 12496-0776-5 | These highlights do not include all the information needed to use PERSERIS ® safely and effectively. See full prescribing information for PERSERIS. PERSERIS (risperidone) for extended-release injectable suspension, for subcutaneous use. Initial U.S. Approval: 1993 | Indivior Inc. | Curia Massachusetts, Inc. | Curia Global, Inc. | Assia Chemical Industries Ltd (Teva Tech site) | Eurofins Lancaster Laboratories, Inc | Isomedix Operations Inc | Nelson Laboratories, LLC | Patheon Manufacturing Services LLC | SGS North America Inc | Sharp Packaging Services, LLC | Spectral Data Services, Inc. | SYNERGY HEALTH AST, LLC | Teva API India Private Ltd. |
| 13107-119 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-119-05 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-119-10 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-119-60 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-120 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-120-05 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-120-10 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-120-60 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-121 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-121-05 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-121-10 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-121-60 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-122 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-122-05 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-122-10 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-122-60 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-123 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-123-05 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-123-10 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-123-60 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-124 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-124-10 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13107-124-60 | These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone tablets, USP. Risperidone Tablets, USP Initial U.S. Approval: 1993 | Aurolife Pharma LLC |
| 13668-035 | These highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE. RISPERIDONE tablet for oral use Risperidone Tablets, USP Initial U.S. Approval: | Rebel Distributors Corp |
| 13668-035 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-035 | These highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE. RISPERIDONE tablet for oral use Risperidone Tablets, USP Initial U.S. Approval 1993 | Physicians Total Care, Inc | Physicians Total Care, Inc. |
| 13668-035-01 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-035-05 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-035-09 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-035-30 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-035-60 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-036 | These highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE. RISPERIDONE tablet for oral use Risperidone Tablets, USP Initial U.S. Approval 1993 | H.J. Harkins Company, Inc. |
| 13668-036 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE Tablets, for oral use Initial U.S. Approval 1993 | RPK Pharmaceuticals, Inc. |
| 13668-036 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-036 | These highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE. RISPERIDONE tablet for oral use Risperidone Tablets, USP Initial U.S. Approval 1993 | Physicians Total Care, Inc | Physicians Total Care, Inc. |
| 13668-036 | These highlights do not include all the information needed to use RISPERIDONE safely and effectively. See full prescribing information for RISPERIDONE. RISPERIDONE tablet for oral use Risperidone Tablets, USP Initial U.S. Approval: | Rebel Distributors Corp |
| 13668-036-01 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-036-05 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-036-30 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-036-54 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |
| 13668-036-60 | These highlights do not include all the information needed to use RISPERIDONE TABLETS safely and effectively. See full prescribing information for RISPERIDONE TABLETS. RISPERIDONE tablets, for oral use Initial U.S. Approval: 1993 | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. |